Maryann Martinovic, MD
Plastic Surgery · Oklahoma City, OKNPI 1528329133
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Motiva USA, LLC at 31.5% of the total. 2025 is the largest year on record at $3,646, 6.8 times the $535 reported in 2019.
Across 136 payments — averaging $81.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Motiva USA, LLC$3K
- RTI Surgical, Inc$2K
- Sientra, Inc.$2K
- Bard Peripheral Vascular, Inc.$738
- Tepha Inc$692
- AbbVie$538
- plus $2K from 33 others
What the payments were for
- Consulting fees$2,49923%
- Speaking & faculty fees$2,00018%
- Travel & lodging$1,57014%
- Food & beverage$4,89244%
- Gifts$871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Motiva USA, LLC | 9 | $3,484 |
| RTI Surgical, Inc | 2 | $2,000 |
| Sientra, Inc. | 15 | $1,563 |
| Bard Peripheral Vascular, Inc. | 7 | $738 |
| Tepha Inc | 4 | $692 |
| AbbVie(2 entities) | 20 | $538 |
| Davol Inc. | 3 | $327 |
| TELA Bio, Inc. | 7 | $229 |
| Merck | 6 | $156 |
| Mentor Worldwide LLC | 2 | $152 |
| Eisai Inc. | 6 | $139 |
| AstraZeneca | 6 | $105 |
| Johnson & Johnson | 4 | $103 |
| Seagen Inc. | 5 | $80 |
| Myriad Genetic Laboratories, Inc. | 3 | $69 |
| Acera Surgical, Inc. | 3 | $67 |
| Amgen | 3 | $62 |
| Lilly USA, LLC | 3 | $60 |
| Sanofi | 3 | $51 |
| Medline Industries LP | 2 | $42 |
| Genmab U.S., Inc. | 2 | $36 |
| Bristol Myers Squibb | 2 | $34 |
| Polynovo North America LLC | 1 | $31 |
| Smith+Nephew | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Medtronic | 1 | $23 |
| Apyx Medical Corporation | 1 | $22 |
| Morphosys, US Inc. | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Fortovia Therapeutics, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Taiho Oncology, Inc. | 1 | $13 |
| Bioptics, Inc. | 1 | $12 |
| Rigel Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Motiva Implant Matrix$3,312
- CORTIVA ALLOGRAFT DERMIS$2,000
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$1,272
- GalaFLEX$516
- Agento I.C. Silver-Coated Endotracheal Tube$159
- MENTOR MemoryGel Resterilizable Gel Sizer$137
- ARTOURA Breast Tissue Expander$137
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$125
How this compares
$11,048 in reported general payments places this provider in the 75th percentile of 35 plastic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 11 | $781 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $318 |
| Ondansetron OdtOndansetron | 68 | $310 |
| Cefadroxil | 46 | $305 |
| Montelukast Sodium | 18 | $134 |
| Oxycodone Hcl | 13 | $47 |
| Tramadol Hcl | 21 | $41 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Oklahoma City
- Anureet BajajOklahoma City$26K
- Justin JonesOklahoma City$20K
- Erik NuveenOklahoma City$20K
- Joel PrinceOklahoma City$18K
- Juan BrouOklahoma City$11K
- Logan ErzOklahoma City$9K
- Lacie WhineryOklahoma City$6K
- Clinton WebsterOklahoma City$6K
- Tim LoveOklahoma City$6K
- Justin van HoorebekeOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.